Literature DB >> 24448289

Vestibular dysfunction in Turner syndrome: a case report.

Michael Baxter1, Yuri Agrawal.   

Abstract

OBJECTIVE: Turner syndrome is a well-known cause of sensorineural hearing loss, and the lack of estrogen has been implicated in cochlear dysfunction. It has never been associated with vestibular dysfunction. We report a case of a patient with Turner syndrome who was found to have bilateral vestibular dysfunction based on video-oculography (VOG) testing. PATIENT: A single patient with a history of Turner syndrome who was found to have significant bilateral vestibular dysfunction. INTERVENTION: After noticing a deficit in the vestibulo-ocular reflexes on qualitative horizontal head impulse examination, the patient underwent VOG testing. MAIN OUTCOME MEASURE: VOG testing quantatively measures angular vestibulo-ocular reflex (AVOR) gain in the horizontal semicircular canal plane. AVOR gain represents the eye movement response to a head movement; in normal individuals the eye movement is fully compensatory and gain values are close to unity.
RESULTS: VOG results showed AVOR gains of 0.29 and 0.36 on the right and left sides, respectively.
CONCLUSION: We have presented a case of a woman with Turner syndrome with asymptomatic vestibular dysfunction demonstrated with VOG testing. Although there is a documented relationship between Turner syndrome and sensorineural hearing loss, there are no previous studies or case reports linking Turner syndrome and vestibular dysfunction. Additional research and added vigilance in monitoring Turner syndrome patients may be warranted.

Entities:  

Mesh:

Year:  2014        PMID: 24448289      PMCID: PMC5654717          DOI: 10.1097/MAO.0b013e31829e16df

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  8 in total

1.  Head impulse testing using video-oculography.

Authors:  Klaus Bartl; Nadine Lehnen; Stefan Kohlbecher; Erich Schneider
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

Review 2.  Estrogen and hearing: a summary of recent investigations.

Authors:  M Hultcrantz; R Simonoska; A E Stenberg
Journal:  Acta Otolaryngol       Date:  2006-01       Impact factor: 1.494

3.  Hearing impairment in Turner's syndrome.

Authors:  H Anderson; R Filipsson; E Fluur; B Koch; J Lindsten; E Wedenberg
Journal:  Acta Otolaryngol       Date:  1969       Impact factor: 1.494

Review 4.  Premenstrual exacerbation of Meniere's disease revisited.

Authors:  James C Andrews; Vicente Honrubia
Journal:  Otolaryngol Clin North Am       Date:  2010-10       Impact factor: 3.346

5.  A longitudinal study of hearing decline in women with Turner syndrome.

Authors:  Christina Hederstierna; Malou Hultcrantz; Ulf Rosenhall
Journal:  Acta Otolaryngol       Date:  2009-12       Impact factor: 1.494

6.  Estrogen and hearing from a clinical point of view; characteristics of auditory function in women with Turner syndrome.

Authors:  Christina Hederstierna; Malou Hultcrantz; Ulf Rosenhall
Journal:  Hear Res       Date:  2008-12-06       Impact factor: 3.208

7.  Otolaryngologic markers for the early diagnosis of Turner syndrome.

Authors:  Tomoko Makishima; Kelly King; Carmen C Brewer; Christopher K Zalewski; John Butman; Vladimir K Bakalov; Carolyn Bondy; Andrew J Griffith
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2009-09-03       Impact factor: 1.675

8.  Estrogen receptors alpha and beta in the inner ear of the 'Turner mouse' and an estrogen receptor beta knockout mouse.

Authors:  A E Stenberg; H Wang; L Sahlin; P Stierna; E Enmark; M Hultcrantz
Journal:  Hear Res       Date:  2002-04       Impact factor: 3.208

  8 in total
  1 in total

1.  Full Spectrum of Reported Symptoms of Bilateral Vestibulopathy Needs Further Investigation-A Systematic Review.

Authors:  Florence Lucieer; Stijn Duijn; Vincent Van Rompaey; Angelica Pérez Fornos; Nils Guinand; Jean Philippe Guyot; Herman Kingma; Raymond van de Berg
Journal:  Front Neurol       Date:  2018-06-04       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.